DK0681580T3 - Prolægemidler af anti-inflammatoriske 3-acyl-2-oxindol-1-carboxamider - Google Patents

Prolægemidler af anti-inflammatoriske 3-acyl-2-oxindol-1-carboxamider

Info

Publication number
DK0681580T3
DK0681580T3 DK93923879.6T DK93923879T DK0681580T3 DK 0681580 T3 DK0681580 T3 DK 0681580T3 DK 93923879 T DK93923879 T DK 93923879T DK 0681580 T3 DK0681580 T3 DK 0681580T3
Authority
DK
Denmark
Prior art keywords
oxindole
carboxamides
prodrugs
acyl
inflammatory
Prior art date
Application number
DK93923879.6T
Other languages
Danish (da)
English (en)
Inventor
Lawrence A Reiter
Kelvin Cooper
Wayne E Barth
Edward F Kleinman
Ralph P Robinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0681580T3 publication Critical patent/DK0681580T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK93923879.6T 1993-01-26 1993-10-20 Prolægemidler af anti-inflammatoriske 3-acyl-2-oxindol-1-carboxamider DK0681580T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/009,188 US5270331A (en) 1993-01-26 1993-01-26 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Publications (1)

Publication Number Publication Date
DK0681580T3 true DK0681580T3 (da) 1997-08-18

Family

ID=21736103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93923879.6T DK0681580T3 (da) 1993-01-26 1993-10-20 Prolægemidler af anti-inflammatoriske 3-acyl-2-oxindol-1-carboxamider

Country Status (35)

Country Link
US (1) US5270331A (ko)
EP (1) EP0681580B1 (ko)
JP (1) JP2703825B2 (ko)
KR (1) KR0169827B1 (ko)
CN (1) CN1052003C (ko)
AP (1) AP443A (ko)
AT (1) ATE155137T1 (ko)
AU (1) AU678187B2 (ko)
BR (1) BR9307768A (ko)
CA (1) CA2152919C (ko)
CZ (1) CZ181995A3 (ko)
DE (1) DE69312093T2 (ko)
DK (1) DK0681580T3 (ko)
EG (1) EG20302A (ko)
ES (1) ES2104187T3 (ko)
FI (1) FI940365A (ko)
GR (1) GR3024591T3 (ko)
HR (1) HRP940034B1 (ko)
HU (1) HUT69689A (ko)
IL (1) IL108384A (ko)
MA (1) MA23096A1 (ko)
MX (1) MX9400677A (ko)
MY (1) MY138629A (ko)
NO (1) NO952949D0 (ko)
NZ (1) NZ257278A (ko)
OA (1) OA10563A (ko)
PL (1) PL178857B1 (ko)
RU (1) RU2124514C1 (ko)
SI (1) SI9300567A (ko)
SK (1) SK280929B6 (ko)
TW (1) TW330935B (ko)
UA (1) UA41348C2 (ko)
WO (1) WO1994017061A1 (ko)
YU (1) YU48796B (ko)
ZA (1) ZA94463B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2155664C (en) * 1993-02-09 1999-06-15 Ralph P. Robinson Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents
WO1997013767A1 (de) * 1995-10-09 1997-04-17 Chemisch Pharmazeutische Forschungsgesellschaft Mbh Heterocyclisch substituierte 1-indolcarboxamide als cyclooxygenase-2 inhibitoren
WO1999044608A1 (en) * 1998-03-06 1999-09-10 Astrazeneca Ab New use
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
AU2002325614A1 (en) * 2001-08-16 2003-03-03 Pharmacon-Forschung Und Beratung Gmbh Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
CN101628842A (zh) * 2009-08-27 2010-01-20 中国人民解放军防化指挥工程学院 烷氧羰基甲氧基作为羧基保护基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
HU208421B (en) * 1988-10-18 1993-10-28 Pfizer Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity

Also Published As

Publication number Publication date
SK280929B6 (sk) 2000-09-12
TW330935B (en) 1998-05-01
EG20302A (en) 1998-10-31
FI940365A (fi) 1994-07-27
JP2703825B2 (ja) 1998-01-26
BR9307768A (pt) 1995-11-21
YU48796B (sh) 2000-03-21
SI9300567A (en) 1994-09-30
KR0169827B1 (en) 1999-01-15
WO1994017061A1 (en) 1994-08-04
EP0681580B1 (en) 1997-07-09
PL309989A1 (en) 1995-11-13
CA2152919C (en) 1999-01-05
DE69312093D1 (de) 1997-08-14
CN1052003C (zh) 2000-05-03
OA10563A (en) 2002-06-05
NO952949L (no) 1995-07-25
IL108384A (en) 1998-12-27
GR3024591T3 (en) 1997-12-31
MX9400677A (es) 1994-08-31
HRP940034B1 (en) 2000-10-31
SK91295A3 (en) 1995-12-06
RU2124514C1 (ru) 1999-01-10
NO952949D0 (no) 1995-07-25
IL108384A0 (en) 1994-04-12
JPH08501316A (ja) 1996-02-13
RU95117091A (ru) 1997-06-27
AU678187B2 (en) 1997-05-22
MY138629A (en) 2009-07-31
ZA94463B (en) 1995-07-24
HRP940034A2 (en) 1996-08-31
NZ257278A (en) 1996-09-25
MA23096A1 (fr) 1994-10-01
US5270331A (en) 1993-12-14
HUT69689A (en) 1995-09-28
AP443A (en) 1996-01-03
HU9400209D0 (en) 1994-05-30
KR960700244A (ko) 1996-01-19
YU2994A (sh) 1997-01-08
ES2104187T3 (es) 1997-10-01
AP9300583A0 (en) 1993-10-31
CN1097740A (zh) 1995-01-25
CZ281046B6 (cs) 1996-06-12
FI940365A0 (fi) 1994-01-25
DE69312093T2 (de) 1997-10-30
CZ181995A3 (en) 1996-06-12
CA2152919A1 (en) 1994-08-04
EP0681580A1 (en) 1995-11-15
UA41348C2 (uk) 2001-09-17
AU5359894A (en) 1994-08-15
ATE155137T1 (de) 1997-07-15
PL178857B1 (pl) 2000-06-30

Similar Documents

Publication Publication Date Title
DK144192D0 (da) Aktivering af enzymer
DE59409721D1 (de) Formulierungen
IS4282A (is) Leysnistýrð skammtaform af Azithromycín
DK0747385T3 (da) Prodrugs af paclitaxel-derivater
DE69309733D1 (de) Lichthärtbare Zusammensetzungen
DK0681580T3 (da) Prolægemidler af anti-inflammatoriske 3-acyl-2-oxindol-1-carboxamider
DE69306706D1 (de) Optischer Wandler
DK0517513T3 (da) Fremstilling af pigmenter
DK0716645T3 (da) Rensning af propofol
DK0689577T3 (da) Anvendelse af ferroncen
NO952485D0 (no) Antiinflammatorisk difluorpentapeptidderivat
FI961227A (fi) Suihkupää
DK0589626T3 (da) Fremstilling af beta-methylcarbapenem-mellemprodukter
EE9700123A (et) Välispidiselt kasutatav põletikuvastane vahend
DK0797547T3 (da) Fremstilling af glasfiberprodukter
DE69305613T2 (de) Härtbare Zusammensetzungen
DK145794A (da) Forbedret fremstilling af rørformede strukturer
DK18593D0 (da) Spaendboesning af ekspansionstypen
DK14493A (da) Fremgangsmaade til fremstilling af pladeformede konstruktionselementer
DK76093D0 (da) Anvendelse af glycosider
DK22293D0 (da) Anvendelse af glycosider
DK0963756T3 (da) Inhibering af avancerede glycosyleringsslutprodukter
KR930022154U (ko) Af카메라용 수광부 구조
KR940020859U (ko) 케이스의 개폐장치
DK71590D0 (da) Theemballage af theposetypen